Daniel Andrew Okin, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Respiratory Paralysis | 1 | 2021 | 32 | 0.770 |
Why?
|
Mevalonic Acid | 1 | 2016 | 46 | 0.520 |
Why?
|
Biosynthetic Pathways | 1 | 2016 | 136 | 0.490 |
Why?
|
Hepatitis | 1 | 2016 | 228 | 0.460 |
Why?
|
Hyperglycemia | 1 | 2016 | 1376 | 0.290 |
Why?
|
Biological Evolution | 1 | 2012 | 1071 | 0.270 |
Why?
|
Prone Position | 1 | 2022 | 196 | 0.190 |
Why?
|
Neoplasms | 4 | 2023 | 22170 | 0.190 |
Why?
|
Diaphragm | 1 | 2021 | 351 | 0.170 |
Why?
|
Inflammation | 2 | 2023 | 10773 | 0.160 |
Why?
|
Edema | 1 | 2022 | 766 | 0.160 |
Why?
|
Inflammasomes | 1 | 2023 | 526 | 0.150 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 445 | 0.140 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 1 | 2016 | 28 | 0.130 |
Why?
|
Protein Prenylation | 1 | 2016 | 70 | 0.130 |
Why?
|
Mice, Obese | 1 | 2016 | 420 | 0.120 |
Why?
|
Respiration, Artificial | 2 | 2024 | 2628 | 0.120 |
Why?
|
rho-Associated Kinases | 1 | 2016 | 281 | 0.120 |
Why?
|
Lung | 2 | 2024 | 10000 | 0.110 |
Why?
|
Dyspnea | 1 | 2021 | 1347 | 0.110 |
Why?
|
Immunocompetence | 1 | 2013 | 138 | 0.100 |
Why?
|
Lung Diseases, Interstitial | 1 | 2021 | 918 | 0.100 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2013 | 133 | 0.100 |
Why?
|
ras Proteins | 1 | 2016 | 1054 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2020 | 1797 | 0.090 |
Why?
|
Fasting | 1 | 2016 | 1603 | 0.080 |
Why?
|
Influenza, Human | 1 | 2020 | 1521 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2206 | 0.080 |
Why?
|
Triglycerides | 1 | 2016 | 2461 | 0.080 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2471 | 0.070 |
Why?
|
Organic Cation Transport Proteins | 1 | 2006 | 61 | 0.070 |
Why?
|
Blood Coagulation | 1 | 2012 | 1154 | 0.070 |
Why?
|
Environment | 1 | 2012 | 1123 | 0.070 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2006 | 223 | 0.060 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 1301 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4652 | 0.060 |
Why?
|
Paracrine Communication | 1 | 2006 | 277 | 0.060 |
Why?
|
Reactive Oxygen Species | 1 | 2012 | 2141 | 0.060 |
Why?
|
Humans | 14 | 2024 | 761504 | 0.050 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 2003 | 116 | 0.050 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7594 | 0.050 |
Why?
|
Blood Glucose | 1 | 2016 | 6391 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2022 | 80636 | 0.050 |
Why?
|
T-Box Domain Proteins | 1 | 2003 | 469 | 0.050 |
Why?
|
Metagenomics | 1 | 2024 | 467 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2012 | 3065 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2024 | 1039 | 0.040 |
Why?
|
Metagenome | 1 | 2023 | 450 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 666 | 0.040 |
Why?
|
Adrenal Gland Diseases | 1 | 2020 | 141 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2006 | 2416 | 0.040 |
Why?
|
Urogenital Neoplasms | 1 | 2020 | 131 | 0.040 |
Why?
|
Middle Aged | 6 | 2024 | 220895 | 0.040 |
Why?
|
Myocytes, Cardiac | 1 | 2006 | 1668 | 0.040 |
Why?
|
Myositis | 1 | 2020 | 271 | 0.040 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2020 | 328 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2024 | 1230 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2020 | 668 | 0.030 |
Why?
|
Female | 7 | 2024 | 392644 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2003 | 2909 | 0.030 |
Why?
|
Bacteria | 1 | 2024 | 2199 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58976 | 0.030 |
Why?
|
Myocarditis | 1 | 2020 | 788 | 0.030 |
Why?
|
Aged | 6 | 2024 | 169289 | 0.020 |
Why?
|
Critical Illness | 1 | 2024 | 2723 | 0.020 |
Why?
|
Mice | 2 | 2016 | 81525 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2548 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2006 | 11528 | 0.020 |
Why?
|
Male | 7 | 2024 | 360804 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2143 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8830 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14605 | 0.020 |
Why?
|
Animals | 3 | 2016 | 168459 | 0.020 |
Why?
|
Cell Aggregation | 1 | 2006 | 239 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2895 | 0.020 |
Why?
|
Spheroids, Cellular | 1 | 2006 | 330 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2006 | 368 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2006 | 618 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 64680 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2003 | 435 | 0.010 |
Why?
|
Mutation | 2 | 2003 | 30052 | 0.010 |
Why?
|
COS Cells | 1 | 2003 | 1130 | 0.010 |
Why?
|
Melanoma | 1 | 2020 | 5709 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10723 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5821 | 0.010 |
Why?
|
Introns | 1 | 2003 | 981 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 1991 | 0.010 |
Why?
|
Ligands | 1 | 2006 | 3272 | 0.010 |
Why?
|
Mutagenesis | 1 | 2003 | 1232 | 0.010 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2003 | 598 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41487 | 0.010 |
Why?
|
Exons | 1 | 2003 | 2391 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2645 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13380 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5774 | 0.010 |
Why?
|
Stem Cells | 1 | 2006 | 3522 | 0.010 |
Why?
|
Models, Molecular | 1 | 2003 | 5439 | 0.010 |
Why?
|
Adult | 2 | 2024 | 221177 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 4243 | 0.010 |
Why?
|
Signal Transduction | 2 | 2006 | 23445 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2006 | 18965 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 17635 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2003 | 11076 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2003 | 2751 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2003 | 4671 | 0.000 |
Why?
|
Adolescent | 1 | 2003 | 88319 | 0.000 |
Why?
|